1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Asymptomatic Condition: new trials by email Literature Review of Asymptomatic Condition trials Research Report on Asymptomatic Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in Asymptomatic GRN-FTD Patients to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VES001 VES001 - Dementia, Frontotemporal Dementia | Phase 1 | Completed | Mads Kjolby | 6 | 2024-12-12 | 2025-08-24 |
| A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers ZY19489 + Ferroquine (FQ), Placebo - Uncomplicated Malaria, Asymptomatic Condition | Phase 1 | Unknown | Zydus Lifesciences Limited | 36 | 2024-08-30 | 2024-10-01 |
Asymptomatic Diseases (2) · Dementia (1) · Frontotemporal Dementia (1) · Malaria, Falciparum (1)
Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Frontotemporal Lobar Degeneration (1) · Infections (1) · Malaria (1) · Mental Disorders (1) · Metabolic Diseases (1) · Mosquito-Borne Diseases (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1) · Nutritional and Metabolic Diseases (1)
ZY-19489 (1) · ferroquine (1)
Mads Kjolby (1) · Zydus Lifesciences Limited (1)
Gabon (1) · Netherlands (1) · United Kingdom (1)